VSTM

VSTM

USD

Verastem Inc. Common Stock

$7.910-1.200 (-13.172%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$9.110

High

$9.279

Low

$7.550

Volume

3.57M

Company Fundamentals

Market Cap

486.8M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

2.47M

Exchange

NCM

Currency

USD

52-Week Range

Low $3.46Current $7.910High $11.25

Related News

BusinessWire

Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Achieved AVMAPKI™ FAKZYNJA™ CO-PACK net product revenue of $11.2 million VS-7375 cleared first two monotherapy dose levels with no dose-limiting toxicities reported; no nausea, vomiting or diarrhea

View more
Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates